Clinical Trial - Trial ChiCTR2200058633
Access comprehensive clinical trial information for ChiCTR2200058633 through Pure Global AI's free database. This Phase 2 trial is sponsored by The First Affiliated Hospital of Guangxi Medical University and is currently Not yet recruiting. The study focuses on Colorectal cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200058633
Phase 2
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2200058633
View on Chinese Clinical Trial Registry
Untitled Trial
A prospective, single-arm, single-center clinical study of Sintilizumab and bevacizumab combined with standard chemotherapy in the second-line treatment of metastatic colorectal cancer
Study Focus
Sponsor & Location
The First Affiliated Hospital of Guangxi Medical University
Self-financing
China
Timeline & Enrollment
Phase 2
N/A
Aug 31, 2024
ICD-10 Classifications
Malignant neoplasm of colon
Malignant neoplasm: Descending colon
Malignant neoplasm: Colon, unspecified
Malignant neoplasm: Ascending colon
Malignant neoplasm: Overlapping lesion of colon
Data Source
Chinese Clinical Trial Registry
ChiCTR2200058633
Non-Device Trial